Get early access! Join the Twelve Data AI Assistant waitlist now.

6467

150.5 TWD
17
12.73%
Last update Aug 20, 1:29 PM CST
Market closed
Day range
130.5
150.5
Previous close
133.5
Open
133.5
Access this stock data via API
Subscribe
Taho Pharmaceuticals Ltd.
150.50
17
12.73%

Statistics

Valuation metrics
Market cap
7.74B
Enterprise value
6.47B
Trailing P/E (ttm)
Forward P/E
PEG ratio
Price/Sales (ttm)
994.98
Price/Book (mrq)
17.34
Enterprise Value/Revenue
831.51
Enterprise Value/EBITDA
-38.35
Overview
Shares outstanding
51.39M
Float
38.44M
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
1.53M
Average volume (90 days)
1.27M
Price summary
52-Week low
32.25
52-Week high
150.50
52-Week change
73.12 226.7%
Beta
50-Day moving average
68.54
200-Day moving average
63.76
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Dec 31, 2024
Profitability
Profit margin
0
Operating margin
-970.23%
Operational effectiveness
Return on assets
-29.12%
Return on equity
-48.14%
Income statement
Revenue (ttm)
7.78M
Revenue per share (ttm)
0.16
Quarterly revenue growth (yoy)
Gross profit (ttm)
4.88M
EBITDA
-168.68M
Net income to common (ttm)
-165.96M
Diluted EPS (ttm)
-3.40
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
401.52M
Total cash per share (mrq)
7.82
Total debt (mrq)
14.01M
Total Debt/Equity (mrq)
3.14
Current ratio (mrq)
3,574.50%
Book value per share (mrq)
8.68
Cash flow
Cash flow statement
-162.46M
Levered free cash flow (LFCF)
-113.11M
Market closed

Exchange is currently closed
Main market opens in 2 hours 5 minutes

06:54
00:00
09:00
13:30
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 13:30
All times are displayed in the Asia/Taipei timezone (CST, UTC+08:00).